Editor in chief
Edelweiss cancer Open Access is interested in publishing research, review manuscripts covering all aspects of cancer. We invite manuscripts which are novel and highly innovative in detecting or curing cancer of all forms. Clinical trial studies, research on new therapeutic agents, drugs and chemicals and new concepts for detection and treatment of cancer.
Edelweiss Cancer Open Access accepts subjects involving multi-subject approach in dealing with cancer, researches concerning to cellular and molecular biology, genetics, clinical trials and epidemiology.
Cancer epidemiology and etiology
Cancer genetic pathways; Cell cycle control
Apoptosis; DNA Repair; Cancer and stem cells
Drugs used in Cancer treatment
DNA Bridges; Prevention studies and education
Cancer cell biology; Melanoma; Non-coding RNA
Cell Proliferation and not limited to above areas.
Edelweiss Cancer Open Access provides a global open access platform to put forth the ongoing research, reviewson cancer. Discussions on clinical aspects that determine the safety and effectiveness of medications, devices, diagnostic products and treatment regimens associated with clinical trials are also welcome in this journal.
Edelweiss Cancer Open Access is an open access journal maintaining high standards of scientific excellence and its editorial board ensures a rapid peer review process with the Manuscript Manager System.